Francesca Lorentino Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2023	Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases.
11/2022	Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis.
2/2022	Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study.
1/2022	Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia.
10/2021	Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience.
1/2021	Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial.
1/2021	Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
1/2020	Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.
1/2020	Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching.
1/2019	Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Lorentino Research Topics

Disease

15	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 08/2015
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2017
6	Leukemia 01/2021 - 01/2017
5	Infections 01/2023 - 12/2016
2	Febrile Neutropenia 01/2023 - 06/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2019
1	Neutropenia 01/2023
1	Residual Neoplasm 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Neoplasms (Cancer) 11/2021
1	Fever of Unknown Origin 06/2021
1	Pneumonia (Pneumonitis) 06/2021
1	Shock 06/2021
1	Intraabdominal Infections 06/2021
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Fever (Fevers) 01/2018
1	Bronchiolitis Obliterans Syndrome 01/2017
1	Pathologic Complete Response 08/2015

Drug/Important Bio-Agent (IBA)

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2017
4	Sirolimus (Rapamycin)FDA Link 01/2023 - 08/2015
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2023 - 01/2017
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 06/2021
2	SteroidsIBA 01/2023 - 10/2021
2	HLA-A Antigens (HLA-A)IBA 01/2020 - 04/2017
1	Levofloxacin (Levaquin)FDA Link 01/2023
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2023
1	FluoroquinolonesIBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 01/2023
1	defibrotideIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	venetoclaxIBA 01/2022
1	ponatinibIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	ruxolitinibIBA 10/2021
1	tazobactam drug combination ceftolozaneIBA 06/2021
1	ceftazidime drug combination avibactamIBA 06/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	LigandsIBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 08/2015
1	treosulfanIBA 08/2015

Therapy/Procedure

14	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2017
6	Therapeutics 01/2023 - 01/2018
5	Transplantation 01/2023 - 08/2015
4	Stem Cell Transplantation 01/2022 - 01/2017
2	Cell Transplantation 01/2020 - 01/2020
1	Salvage Therapy 01/2022
1	Drug Therapy (Chemotherapy) 06/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017
1	Haploidentical Transplantation 12/2016